{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:56:19Z","timestamp":1789977379076,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Pfizer Pharma"},{"name":"German Ministry of Health","award":["IIA5-2511NIK001\/321-4533-06"],"award-info":[{"award-number":["IIA5-2511NIK001\/321-4533-06"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.vaccine.2017.11.085","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T08:42:20Z","timestamp":1513413740000},"page":"572-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Invasive pneumococcal disease in children under 16\u202fyears of age: Incomplete rebound in incidence after the maximum effect of PCV13 in 2012\/13 in Germany"],"prefix":"10.1016","volume":"36","author":[{"given":"Raphael","family":"Weinberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"von Kries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8799-8744","authenticated-orcid":false,"given":"Thorsten","family":"Rieck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Siedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Falkenhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.11.085_b0005","unstructured":"Centers for Disease Control and Prevention CDC. Progress in introduction of pneumococcal conjugate vaccine-worldwide. 2000\u20132012, MMWR. Morbidity and mortality weekly report (2013); 62(16):308."},{"issue":"1","key":"10.1016\/j.vaccine.2017.11.085_b0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12879-015-1147-x","article-title":"Pneumococcal serotype evolution in Western Europe","volume":"15","author":"Htar","year":"2015","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2017.11.085_b0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"The Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.vaccine.2017.11.085_b0020","doi-asserted-by":"crossref","first-page":"e0177113","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis","volume":"12","author":"Balsells","year":"2017","journal-title":"PloS one"},{"issue":"5","key":"10.1016\/j.vaccine.2017.11.085_b0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"The Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.085_b0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-0030-1247587","article-title":"Process and outcome quality of the German Paediatric Surveillance Unit (ESPED)","volume":"222","author":"G\u00f6bel","year":"2010","journal-title":"Klinische Padiatrie."},{"key":"10.1016\/j.vaccine.2017.11.085_b0035","doi-asserted-by":"crossref","unstructured":"Weiss S, Falkenhorst G, Linden M, Im\u00f6hl M, Kries Rv. Impact of 10-and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012. Eurosurveillance 2015;(10).","DOI":"10.2807\/1560-7917.ES2015.20.10.21057"},{"issue":"40","key":"10.1016\/j.vaccine.2017.11.085_b0040","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1016\/j.vaccine.2012.06.068","article-title":"Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children","volume":"30","author":"van der Linden","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.085_b0045","unstructured":"Robert Koch Institute (RKI). Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut: Pneumokokken-Indikationsimpfung. Epidemiologisches Bulletin. 2014;34:313. Available from: <https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2014\/ Ausgaben\/34_14.pdf? __blob=publicationFile>."},{"issue":"8791","key":"10.1016\/j.vaccine.2017.11.085_b0050","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0140-6736(92)91103-F","article-title":"Counting birds, bees, and NCDs","volume":"339","author":"Laporte","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.11.085_b0055","unstructured":"Armitage P, Berry G, Matthews JNS. Statistical methods in medical research: John Wiley & Sons; 2008."},{"key":"10.1016\/j.vaccine.2017.11.085_b0060","unstructured":"Federal Statistical Office of Germany. Current updating of population figures: Germany, reference date, age. <https:\/\/www-genesis.destatis.de\/genesis\/online\/data;jsessionid=A64AF35A7F4554E77CE787C080053233.tomcat_GO_2_2?operation=abruftabelleAbrufen&selectionname=12411-0005&levelindex=0&levelid=1499416977243&index=5> [accessed May 23, 2017]."},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.085_b0065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4161\/hv.26986","article-title":"Vaccination coverage among children in Germany estimated by analysis of health insurance claims data","volume":"10","author":"Rieck","year":"2014","journal-title":"Human Vacc. Immunotherap."},{"issue":"38","key":"10.1016\/j.vaccine.2017.11.085_b0070","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1016\/j.vaccine.2016.07.038","article-title":"Impact of PCV7\/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD","volume":"34","author":"Ben-Shimol","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.085_b0075","article-title":"Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: insights from Israeli surveillance studies","author":"Ben-Shimol","year":"2017","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2017.11.085_b0080","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality","volume":"59","author":"Harboe","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.085_b0085","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.vaccine.2014.11.011","article-title":"Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001\u20132012","volume":"33","author":"Lepoutre","year":"2015","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2017.11.085_b0090","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1016\/j.vaccine.2013.10.032","article-title":"Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway","volume":"31","author":"Steens","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.085_b0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12879-015-1147-x","article-title":"Pneumococcal serotype evolution in Western Europe","volume":"15","author":"Tin Tin Htar","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.vaccine.2017.11.085_b0100","unstructured":"Arbeitsgemeinschaft Influenza (AGI, Robert Koch-Institute Influenza Working Committee). Saisonbericht (report of the season). <https:\/\/influenza.rki.de\/Saisonbericht>. [accessed July 10, 2017]."},{"key":"10.1016\/j.vaccine.2017.11.085_b0105","doi-asserted-by":"crossref","unstructured":"Oligbu G, Collins S, Sheppard CL, Fry NK, Slack M, Borrow R, et al. Childhood deaths attributable to invasive pneumococcal disease in England and Wales, 2006\u20132014. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America; 2017.","DOI":"10.1093\/cid\/cix310"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17317541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17317541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:03Z","timestamp":1759400703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17317541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0264410X17317541"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive pneumococcal disease in children under 16\u202fyears of age: Incomplete rebound in incidence after the maximum effect of PCV13 in 2012\/13 in Germany","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}